Orthocell (ASX:OCC) Presentation, FNN Investor Event, September 2018, Sydney

Company Presentations

Orthocell Limited (ASX:OCC) Managing Director, Paul Anderson presents on advances in regenerative medicine, the company's product line up and commercialisation.

Key points:


- Relatively new field of medicine that seeks to repair injured or diseased tissue by harnessing the body’s own regenerative capabilities

- CelGro Soft tissue reconstruction platform medical device

- Ortho-ATI regeneration of tendons cell therapy

- Large unmet clinical need

- Optimised manufacturing capability

- Ageing population and rising musculoskeletal disorders

- Demand for safe, efficient and cost effective treatments

For more information, watch Managing Director, Paul Anderson present.